BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 28, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 20, 1999
View Archived Issues
Long-term beneficial effects of orlistat reported in JAMA
Read More
Idun obtains rights to technology with application to HIV and other diseases
Read More
LeukoSite acquires CytoMed programs in asthma and inflammation
Read More
Nitromethyl ketones from Merck KGaA protect against diabetic complications
Read More
Melatonergic agents in development at Bristol-Myers Squibb
Read More
Ortho-McNeil reports new treatments for BPH
Read More
More on AMPA antagonists under study at Pfizer
Read More
NOS inhibitors with selectivity for the neuronal isoform synthesized at Schering AG
Read More
Preparation and use of dopamine D3 receptor modulators disclosed by SB
Read More
DuPont describes new HIV protease inhibitors
Read More
Generic form of Ritalin approved by FDA
Read More
New treatment option for Gaucher's disease patients in Germany
Read More
New market introduction for Organon's anticoagulant
Read More
Potential new use for Anticort to be tested in Romania
Read More
Zidovudine exposure in infancy not associated with adverse effects later in childhood
Read More
SAR studies on biphenylsulfonamides lead to BMS-187308, an orally active endothelin antagonist
Read More
Novel pure mu/kappa-opioid receptor antagonist as a lead in the field of drug abuse therapy
Read More
XK-469, an analogue of the herbicide Assure, in clinical testing as antitumor agent
Read More
New formulation may facilitate clinical development of antagonist G
Read More
Pfizer launches Trovan in Canada
Read More
PDL issues further licenses under its antibody humanization patents
Read More
Pharmacia & Upjohn provides additional funding for Miravant's SnET2
Read More
Biovail signs multifaceted agreement with Lundbeck for citalopram
Read More
ProCyte and Merck enter distribution agreement
Read More
SNAP-5540: a uroselective adrenergic BPH agent
Read More
Cantab studies validate novel approach to treating IBD
Read More
PARP inhibitors potentiate cytotoxicity of alkylating agents, bleomycin and radiation
Read More
Immune Response receives USD 5 million payment from Agouron
Read More
